et al (2015) accuracy asymptomatic women with an abnormal screening mammogram. and breast ultrasound were performed before biopsy and all imaging modalities were compared by lesion-by-lesion analyses. Dec 2015 Cochet A et al (2014) Recurrence Retrospective Change in management The utility of 18 F-FDG PET/CT for suspected recurrent breast cancer: impact and prognostic stratification Sixty-three patients who were referred to our institution for suspicion of BC relapse were retrospectively enrolled. All patients had been evaluated with CI and underwent PET/CT. At a median follow-up of 61 months, serial clinical, imaging and pathologic results were obtained to validate diagnostic findings. Overall Survival (OS) was estimated using Kaplan Meier methods and analyzed using the Cox proportional hazards regression models. Cancer imaging: the official publication of the International Cancer Imaging Society. 14 (pp 13), 2014. Date of Publication: 2014. 2014 Dizendorf EV, et al. (2003) Change in management Impact of whole-body PET on staging and managing patients for radiation therapy Whole-body PET was performed in 202 patients with different malignant tumours before radiation therapy. The alteration of PET on each patient’s staging and management decisions for radiation therapy were determined. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine. 44 (1) (pp 24-29), Jan 2003 2003 Dong Y et al (2015) Non-randomised Comparative diagnostic accuracy The diagnostic value of PET/CT in association with serum tumor marker assays in breast cancer recurrence and metastasis. Comparative diagnostic accuracy of PET/CT versus conventional imaging in 26 patients with suspected mestastases / recurrence. Dong Y et al BioMed research international. 2015 (pp 489021) 2015 Evangelista L. et al (2016) Retrospective Diagnostic accuracy Diagnostic and Prognostic of 18F-FDG PET/CT in Male Breast Cancer: Results from a Bicentric Population. The diagnostic and prognostic values of FDG-PET/CT in 25 men with a proven breast cancer diagnosis was assessed. The prognostic impact of PET/CT was assessed by using Kaplan-Meier analysis. Current Radiopharmaceuticals. 9 (2) (pp. 169-177), 2016 2016
(2016) Comparative diagnostic accuracy at the postoperative surveillance in the breast cancer patients. conventional imaging in 1161 patients with suspected metastases and/or recurrent BC (pp 141-148), 2016. Kim YH et al (2015) Suspected metastases PET prognosis The clinical significance of standardized uptake value in breast cancer measured using positron emission tomography/computed tomography. The objective of this study was to investigate the clinical and biological significance of F-FDG) uptake levels in breast cancer patients. PATIENTS AND METHODS: F-FDG PET/CT was performed in 206 women with breast cancer, and the standardized uptake value (SUV) in breast cancer was analyzed to test associations with prognostic parameters. 2015 Koolen BB . et al (2014) Non-randomised Comparative diagnostic accuracy Accuracy of 18F-FDG PET/CT for primary tumor visualization and staging in T1 breast cancer. Comparative diagnostic accuracy of PET/CT versus conventional imaging in 62 patients with LABC. Koolen BB . et al. Acta Oncologica. 53 (1) (pp 50-57), 2014.) 2014 Krammer J et al (2015) Suspected metastases Change in management (18)F-FDG PET/CT for initial staging in breast cancer patients - Is there a relevant impact on treatment planning compared to conventional staging modalities? To evaluate the impact of whole-body 18F-FDG PET/CT on initial staging of breast cancer in comparison to conventional staging modalities. N=101 patients. Preoperative whole-body staging with PET/CT was performed in patients with clinical stage>T2 tumours or positive local lymph nodes (n=91). Postoperative PET/CT was performed in patients without these criteria but positive sentinel lymph node biopsy (n=10). All patients underwent PET/CT and a conventional staging algorithm, which included bone scan, chest X-ray and abdominal ultrasound. PET/CT findings were compared to conventional staging and the impact on therapeutic management was evaluated. European radiology. 25 (8) (pp 2460-2469), 2015. Date of Publication: 01 Aug 2015. 2015
You S et al (2015) Non-randomised Comparative diagnostic accuracy Evaluation of lymph node status after neoadjuvant chemotherapy in breast cancer patients: comparison of diagnostic performance of ultrasound, MRI and PET/CT Comparative diagnostic accuracy of PET/CT versus conventional imaging in 191 patients with suspected BC metastases You S et al. The British journal of radiology. 88 (1052) (pp 20150143), 2015. 2015 * Categorise study design, for example meta-analysis, randomised trials, non-randomised trial or observational study, study of diagnostic accuracy, etc. **Provide high level information including population numbers and whether patients are being recruited or in post-recruitment, including providing the trial registration number to allow for tracking purposes. *** If the publication is a follow-up to an initial publication, please advise.